Latest Bioethics Stories
"It’s simply magnificent.
DENVER, May 1, 2014 /PRNewswire/ -- Cal-Bay International, Inc.
LEXINGTON, Massachusetts, April 30, 2014 /PRNewswire/ -- - OPUS-2, a Phase 3 placebo-controlled study of lifitegrast 5.0%; results presented at
Listen Live on Coast to Coast with George Noory as Dr.
Clinical Trials Point Toward 'ATX-101' as Potential Noninvasive Solution for Reduction of Submental Fat SAN FRANCISCO, April 26, 2014 /PRNewswire-USNewswire/ -- Skin laxity and fat buildup
PHILADELPHIA, April 24, 2014 /PRNewswire-USNewswire/ -- A new study suggests that targeting B cells, which are a type of white blood cell in the immune system, may be associated with reduced
As a professor of law and ethics, Rebecca Dresser had been teaching and writing for years about dealing with cancer.
DUBLIN, April 18, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ddkpws/mice_model_market) has announced the addition of the "Mice
TORONTO, April 16, 2014 /CNW/ - Ontario's doctors are helping to mark Advance Care Planning Day today by encouraging everyone to take a moment and consider their end-of-life wishes. Advance
TOKYO, April 16, 2014 /PRNewswire/ -- Ajinomoto Pharmaceuticals Co., Ltd.
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.
More Images (1 images) »